Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.42 | 4.81 |
| PEG Ratio (TTM) | 0.17 | -1.08 |
| P/S Ratio (TTM) | 13.51 | 51.93 |
| P/B Ratio (TTM) | 0.92 | 0.94 |
| P/FCF Ratio (TTM) | 10.72 | 18.49 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.70 |
| Price to 5YR AVG FCF Ratio | N/A | 29.10 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.48% | 1.17% |
| ROE (TTM) | 3.48% | 5.34% |
| Net Profit Margin (TTM) | 51.13% | 28.56% |
| ROIC 5YR AVG | N/A | 7.78% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 86.46% | 128.46% | N/A |
| Revenue | -0.36% | 176.82% | N/A |
| Net Income | 86.77% | 103.15% | N/A |
| Cash Flow | -32.17% | 79.43% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.10 | 1.63 |
| Quick Ratio (TTM) | 0.10 | 1.59 |
| D/E Ratio (TTM) | 0.40 | 0.72 |
| Interest Coverage (TTM) | 11.93 | 19.98 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 1.03 | 7.47 |
| LTL to 5YR AVG FCF | N/A | 9.40 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.98% |